Connect with us
Biotest, a Grifols group company, expects $1 billion in US sales of its immunoglobulin drug Yimmugo over the next seven years, following FDA approval. Grifols shares...
Grifols and PharmaMar significantly dropped Spanish pharmaceutical stocks, with declines of 49.1% and 22.5% respectively in the first half of 2024. Although other companies like Rovi...
Grifols rose almost 3% on the stock market at the start of the trading day this Friday, after the Catalan firm assured that it will be...
Sanofi seeks a buyer for its consumer healthcare division, valued at around 20 billion euros, with offers due by mid-July. Interested parties include Advent International, PAI...
Augustine Therapeutics raised 17 million euros in the first closing of a Series A round led by Asabys Partners. Eli Lilly & Company and the CMT...
Faes Farma is expanding its Vizcaya investment from €150 million to €200 million. The new Derio plant, ready to start in early 2025 pending Aemps authorization,...
Better Care is entering the US market, aiming to quadruple its income to five million euros, says CEO Xavier García Ordoñez. Operating in 35 European hospitals...
The Institute of Knowledge Engineering (IIC) has developed 'Bialert Sepsis,' an AI tool predicting sepsis risk 24 hours in advance with 96% accuracy. It continuously collects...
Oryzon Genomics is seeking to trade 378,918 new shares on Spain's major stock exchanges after increasing its share capital by €18,945.90. Private equity firm Nice&Green converted...
The Amancio Ortega Foundation is investing 59 million euros to build the Únicas SJD precision medicine research center for rare diseases, part of the Porta Diagonal...
 |
|
 |  |
 |
|